Jeffrey Berkowitz

Jeffrey Berkowitz

Director/Board Member presso BRAEBURN INC.

Patrimonio netto: 873 541 $ in data 31/03/2024

58 anni
Health Technology
Commercial Services
Technology Services

Profilo

Jeffrey Berkowitz is currently the Chief Executive Officer & Director at Real Endpoints LLC.
He is also the Chairman at Pharma Two B Ltd.
Additionally, he serves as an Independent Director at H.
Lundbeck A, Director at Click Therapeutics, Inc., Independent Director at Zealand Pharma A, Director at Braeburn, Inc., Senior Advisor at Permira Advisers LLP, and Venture Advisor at Israel Biotech Fund.
In his former positions, Mr. Berkowitz served as an Independent Director at Esperion Therapeutics, Inc. from 2017 to 2023.
He was also an Independent Director at Infinity Pharmaceuticals, Inc. from 2014 to 2020.
He held the position of Director at Swiss-American Chamber of Commerce, Aptus Health, Inc., Physicians Interactive Holdings LLC, ZappRx, Inc., and UnitedHealth Group, Inc. He was the Senior Vice President-Global Market Access at Merck & Co., Inc. and Vice President-Global Market Access at Schering-Plough Corp.
He served as the Executive Vice President at UnitedHealth Group, Inc., InGensa, Inc., and Optum, Inc. He was the SVP-Pharmaceutical Development & Market Access at Walgreen Co. and EVP, President-Pharma & Global Market Access at Walgreens Boots Alliance, Inc. He was also the Co-President at Walgreens Boots Alliance Development GmbH.
Mr. Berkowitz received his undergraduate degree from Union College (New York) and his graduate degree from Brooklyn Law School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/12/2023 8 200 ( 0.01% ) 810 698 $ 31/03/2024
28/03/2023 23 449 ( 0.01% ) 62 843 $ 31/03/2024

Posizioni attive di Jeffrey Berkowitz

SocietàPosizioneInizio
H. LUNDBECK A/S Director/Board Member 20/03/2018
ZEALAND PHARMA A/S Director/Board Member 04/04/2019
BRAEBURN INC. Director/Board Member 01/12/2017
Consultant / Advisor -
Director/Board Member -
Chairman 12/08/2021
Chief Executive Officer 13/09/2018
Consultant / Advisor 08/11/2023
Tutte le posizioni attive di Jeffrey Berkowitz

Precedenti posizioni note di Jeffrey Berkowitz

SocietàPosizioneFine
UNIPHAR PLC Director/Board Member 16/01/2024
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Jeffrey Berkowitz

Formazione di Jeffrey Berkowitz

Union College (New York) Undergraduate Degree
Brooklyn Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jeffrey Berkowitz

Relazioni

100 +

Relazioni di 1° grado

26

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
MERCK & CO., INC.

Health Technology

UNITEDHEALTH GROUP INC.

Health Services

ESPERION THERAPEUTICS, INC.

Health Technology

H. LUNDBECK A/S

Health Technology

INFINITY PHARMACEUTICALS, INC.

Health Technology

ZEALAND PHARMA A/S

Health Technology

WALGREENS BOOTS ALLIANCE, INC.

Retail Trade

UNIPHAR PLC

Distribution Services

Aziende private16

Health Technology

Retail Trade

Technology Services

Finance

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Technology Services

Commercial Services

Health Technology

Finance

Commercial Services

Technology Services

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Jeffrey Berkowitz